F. Sadeghipour

Discipline

Psychologie (2) Histoire, Philosophie et Sociologie des sciences (1) Gestion et management (1)

Type de document

Articles (8) Recensions (1) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

hôpital (4) temps (durée) (3) analyse (3) dose (3) dosage (3) prescription (3) Treatment (3) Year (3) Time (3) Patients (3) Analysis (3) Patients (3) thérapie (2) pression (2) chromatographie (2) méthode (2) cardiologie (2) Lausanne (2) Identification (2) Therapeutics (2) Proportion (2) Pressure (2) Prescription writing (2) Medicine--Formulae, receipts, prescriptions (2) Mass (2) Identification (2) Hospital pharmacies (2) Myocardial infarction (2) Evidence (2) Chromatographic analysis (2)

Documents écrit par F. Sadeghipour (9) | parle de F. Sadeghipour (0)

Development of a generic approach for monitoring leachable compounds in hospital pharmacy-prepared prefilled plastic packaging by ultrahigh-performance liquid chromatography coupled to high-resolution mass spectrometry with postcolumn infusion.
W. Bello et al. (30 nov. 2023)
Transplantation de microbiote fécal : de l’évidence aux réalités du terrain [Fecal microbiota transplantation: from the evidence to the realty of the field]
A. Ballif et al. (14 avr. 2021)
Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study.
M. Franchitti et al. (24 août 2020)
Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study.
C. Bruggmann et al. (10 août 2020)
Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
C. Bruggmann et al.
Description and analysis of hospital pharmacies in Madagascar
H.R. Ratsimbazafimahefa et al.
Stop using the flotation technique and start weighing salbutamol pressurised metered-dose inhalers without dose counters.
E.R. Di Paolo et al. (2015)
Discharge plan for patient with heart failure: it is worth to have a clinical pharmacist in the team
C. Nachar et al. (2014)
2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.
C. Giroud et al. (1998)